GLP-1 Drugs

GLP-1 Drugs Context: The World Health Organization (WHO) issued its first ever global guidelines on the use of medications for obesity management.
The Glucagon-like peptide-1 (GLP-1) or GLP-1 receptor agonists are synthetic drugs which are being used for the treatment of obesity in adults.  GLP-1 receptor agonists are a class of medicines that help lower blood sugar and support weight loss in people with type 2 diabetes.
Two leading GLP-1 drugs are: Semaglutide and Tirzepatide. 
GLP-1 is a hormone that your small intestine makes.
Roles of GLP-1  hormone : 
•    Triggering insulin release from your pancreas to lower the amount of glucose (sugar) in blood.
•    Blocking glucagon secretion to prevent more glucose from going into the bloodstream.
•    Slowing gastric emptying, preventing sudden spikes in blood sugar.
GLP-1 agonist medications work by mimicking hormones. 
GLP-1 medications bind to GLP receptors to trigger the effects (or roles) of the GLP-1 hormone. 
The higher the dose of the GLP-1 agonist, the more extreme the effects.